Prognostic Testing for Prostate Cancer—A Cost-Effectiveness Analysis Comparing a Prostatype P-Score Biomarker Approach to Standard Clinical Practice
PharmacoEconomics · 2025
DOI: 10.1007/s40273-024-01466-9 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift PharmacoEconomics, 2025. Verfasst von Adam Fridhammar und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Swedish Institute for Health Economics, Lund, Sweden. adam.fridhammar@ihe.se. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sponsorship for this analysis and article was provided by Prostatype Genomics AB to the Swedish Institute for Health Economics.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Swedish Institute for Health Economics, Lund, Sweden. adam.fridhammar@ihe.se.
- The Swedish Institute for Health Economics, Lund, Sweden.
- Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden.
- Prostatype Genomics AB, Stockholm, Sweden.
- Department of Urology, Uppsala University Hospital, Uppsala, Sweden.
- Department of Clinical Sciences, Lund University, Lund, Malmö, Sweden.
ORCID-Profile: Adam Fridhammar, Oskar Frisell, Karin Wahlberg, Emelie Berglund, Pontus Röbeck, Sofie Persson
Förderung
- Sponsorship for this analysis and article was provided by Prostatype Genomics AB to the Swedish Institute for Health Economics
Zitieren
APA
Fridhammar, A., Frisell, O., Wahlberg, K., Berglund, E., Röbeck, P., & Persson, S. (2025). Prognostic Testing for Prostate Cancer—A Cost-Effectiveness Analysis Comparing a Prostatype P-Score Biomarker Approach to Standard Clinical Practice. PharmacoEconomics. https://doi.org/10.1007/s40273-024-01466-9
Vancouver
Fridhammar A, Frisell O, Wahlberg K, Berglund E, Röbeck P, Persson S. Prognostic Testing for Prostate Cancer—A Cost-Effectiveness Analysis Comparing a Prostatype P-Score Biomarker Approach to Standard Clinical Practice. PharmacoEconomics. 2025. doi:10.1007/s40273-024-01466-9
BibTeX
@article{Fridhammar2025,
author = {Fridhammar, Adam and Frisell, Oskar and Wahlberg, Karin and Berglund, Emelie and Röbeck, Pontus and Persson, Sofie},
title = {Prognostic Testing for Prostate Cancer—A Cost-Effectiveness Analysis Comparing a Prostatype P-Score Biomarker Approach to Standard Clinical Practice},
journal = {PharmacoEconomics},
year = {2025},
doi = {10.1007/s40273-024-01466-9}
}
EUVIMED